4//SEC Filing
ADAMS ERIC A 4
Accession 0001213900-20-043355
CIK 0001728328other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 6:08 AM ET
Size
5.6 KB
Accession
0001213900-20-043355
Insider Transaction Report
Form 4
ADAMS ERIC A
DirectorCEO & President10% Owner
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-12-16+125,000→ 125,000 totalExercise: $3.02Exp: 2025-12-15→ Common shares (125,000 underlying)
Footnotes (2)
- [F1]The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00.
- [F2]The options were granted on 12/16/2020 and will vest as follows: 25% on 6/16/2021; 25% on 12/16/2021; 25% on 6/16/2022; and 25% on 12/16/2022.
Documents
Issuer
InMed Pharmaceuticals Inc.
CIK 0001728328
Entity typeother
Related Parties
1- filerCIK 0001817882
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 6:08 AM ET
- Size
- 5.6 KB